Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Advances in Radiation Oncology|September 15, 2025
Case Volume and Experience in Stereotactic Radiation: Analysis of a Prospective Peer Review ProgramLuke Peng, Kee-Young Shin, Tara Kosak, et al.
AIDS Patient Care and Stds|May 26, 2021
Salient Constructs for the Development of Shared Decision-Making Tools for HIV Pre-Exposure Prophylaxis Uptake and Regimen Choice: Behaviors, Behavioral Skills, and BeliefsKathrine Meyers, Yumeng Wu, Kee-Young Shin, et al.
Advances in Radiation Oncology|February 25, 2026
Prospective Evaluation of Stereotactic Body Radiation Therapy for Reirradiation of Bone MetastasesLubna Hammoudeh, Kee-Young Shin, Lauren Hertan, et al.
Cancer|July 24, 2023
Acute toxicity comparison of magnetic resonance-guided adaptive versus fiducial or computed tomography-guided non-adaptive prostate stereotactic body radiotherapy: A systematic review and meta-analysisJonathan E Leeman, Kee-Young Shin, Yu-Hui Chen, et al.
Cancer|August 5, 2024
Changes in Merkel cell oncoprotein antibodies after radiation therapy in curatively treated Merkel cell carcinoma and association with recurrenceKevin X Liu, Kee-Young Shin, Manisha Thakuria, et al.
Annals of Palliative Medicine|July 11, 2022
Longitudinal symptoms and temporal trends in palliative care, palliative radiotherapy, and anti-cancer treatment near end of life among patients with metastatic cancerJie Jane Chen, Kee-Young Shin, Peter J Hong, et al.
Transplantation and Cellular Therapy|May 27, 2022
Comparison of Pulmonary Toxicity after Total Body Irradiation- and Busulfan-Based Myeloablative Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric PatientsKevin X Liu, Nicolas Poux, Kee-Young Shin, et al.
Clinical Lung Cancer|February 22, 2025
Association of Sarcopenia With Toxicity and Survival in Patients With Lung Cancer, a Multi-Institutional Study With External Dataset ValidationAnurag Saraf, John He, Kee-Young Shin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2025
Elraglusib, a Glycogen Synthase Kinase 3β Inhibitor, plus Chemotherapy with or without Immunotherapy in Patients with Recurrent, Metastatic Salivary Gland CarcinomaGlenn J Hanna, Nicole Scarfo, Kee-Young Shin, et al.
Neuro-Oncology|May 11, 2026
Association between radiographic response and subsequent recurrence in brain metastases treated with radiation: implications for response assessment criteriaBenjamin Grobman, Nayan Lamba, Sandeep Purohit, et al.
Pageof 3